Skip to main content
. 2024 Mar 14;11:1381492. doi: 10.3389/fmed.2024.1381492

Table 3.

Specimen characteristics in IPs and NIPs.

Total (N = 292) BCCs in NIPs (N = 134) BCCs in IPs (N = 158) p-value
Size (mm), mean (SD) 14.55 (11.15) 14.44 (10.90) 14.65 (11.39) 0.2577 a
Size group (mm) <10 92 (31.51%) 49 (36.57%) 43 (27.22%) 0.0806 b
10–30 175 (59.93%) 71 (52.98%) 104 (65.82%)
>30 25 (8.56%) 14 (10.45%) 11 (6.96%)
Subtypes Superficial 124 (42.46%) 59 (44.03%) 65 (41.14%) 0.1727 c
Nodular 58 (19.86%) 23 (17.16%) 35 (22.15%)
Ulcerated 47 (16.10%) 19 (14.18%) 28 (17.72%)
Pigmented 7 (2.40%) 1 (0.75%) 6 (3.80%)
Infiltrative 27 (9.25%) 14 (10.45%) 13 (8.23%)
Others 29 (9.93%) 18 (13.43%) 11 (6.96%)
Localization area Intermittently/not sun-exposed areas 119 (40.75%) 57 (42.54%) 62 (39.24%) 0.6514 b
Photo-exposed areas 173 (59.25%) 77 (57.46%) 96 (60.76%)
Localization Trunk 105 (35.96%) 47 (35.07%) 58 (36.71%) 0.3328 d
Limbs 14 (4.79%) 10 (7.46%) 4 (2.53%)
Nose 66 (22.61%) 31 (23.14%) 35 (22.15%)
Cheeks 54 (18.49%) 20 (14.93%) 34 (21.52%)
Frontotemporal 28 (9.59%) 15 (11.19%) 13 (8.23%)
Ears 7 (2.40%) 3 (2.24%) 4 (2.53%)
Scalp 10 (3.42%) 3 (2.24%) 7 (4.43%)
Neck 8 (2.74%) 5 (3.73%) 3 (1.90%)

IP, immunosuppressed patient; NIP, non-immunosuppressed patient.

a

Mann–Whitney test.

b

Chi-square test.

c

Fisher exact test.

d

Fisher exact test with simulated p-value.